CHAARM Forum
Do you have a question to ask to CHAARM
partners or have any information to share?
We are here to talk with other experts or non-
experts, and our research can benefit from
these exchanges as well!
So, don't be shy, we are looking forward to hearing from you!
- Login to post comments
Comments
A very informative article
A very informative article and lots of really honest and forthright comments made ! This certainly got me thinking about this issue, thanks all. Socialite Life
I am glad to read this post,
I am glad to read this post, its an interesting one. I am always searching for quality posts and articles and this is what I found here, I hope you will be adding more in future. Thanks color laser toner
I just stumbled upon your
I just stumbled upon your blog and wanted to say that I have really enjoyed reading your blog posts. Any way I'll be subscribing to your feed and I hope you post again soon. Crescent Processing
This is a terrific article,
This is a terrific article, and I would like more information if you have any. I am fascinated with this topic and your post has been one of the best I have read. rapidshare download
There is so many people that
There is so many people that run into these leaks. The price of water can increase so much. I am glad that the town is doing something about it. There is so much to get from it. Flowers
CHAARM brings together some
CHAARM brings together some of the top researchers and scientists from around the world. It is a consortium of 31 partners from academic institutions, research organizations, small and medium enterprises, and larger industries.
shopping cart software | malaysia ecommerce | e-commerce solution | ecommerce | e-commerce software
Thirty years of a disease
From the printed edition of The Economist
On JUNE 5th 1981 America’s Centres for Disease Control and Prevention reported the outbreak of an unusual form of pneumonia in Los Angeles. When, a few weeks later, its scientists noticed a similar cluster of a rare cancer called Kaposi’s sarcoma in San Francisco, they suspected that something strange and serious was afoot. That something was AIDS.
Since then, 25m people have died from AIDS and another 34m are infected. The 30th anniversary of the disease’s discovery has been taken by many as an occasion for hand-wringing. Yet the war on AIDS is going far better than anyone dared hope. A decade ago, half of the people in several southern African countries were expected to die of AIDS. Now, the death rate is dropping. In 2005 the disease killed 2.1m people. In 2009, the most recent year for which data are available, the number was 1.8m. Some 5m lives have already been saved by drug treatment. In 33 of the worst-affected countries the rate of new infections is down by 25% or more from its peak.
Read more on the online version of The Economist
New calls for proposals on HIV/AIDS research
The orientation paper of the European Commission next calls for proposals in the HEALTH area has been published today in its draft version.
New funding available for research on HIV/AIDS this year:
HEALTH.2012.2.3.2-1: Co-infection of HIV/AIDS, malaria, tuberculosis and/or hepatitis.
FP7-HEALTH-2012-INNOVATION-1. The objective of this topic is to support basic, translational and/or clinical research with the aim of improving basic knowledge,disease prevention, therapeutic management and prognosis of patients that are co-infected with two or more of the infectious agents causing AIDS, malaria, tuberculosis or hepatitis.
The proposals are expected to address key research questions, such as immunological mechanisms and responses to co-infection, and may include investigator driven clinical trials on prevention, treatment or treatment combinations for co-infected individuals as well as clinical and epidemiological consequences.
HEALTH.2012.2.3.2-2: Co-morbidity between infectious and non-communicable diseases.
FP7-HEALTH-2012-INNOVATION-1. Increasing evidence suggests that pathologies of many infectious diseases can be strongly influenced by concurrent presence in the same individual of non-infectious diseases, or vice-versa. The objective of this topic is to support basic, translational and/or clinical research with the aim of improving basic knowledge, disease prevention, therapeutic management and prognosis of patients with both infectious and non-communicable diseases. The proposals are expected to elucidate and clarify causative links between infectious and non-communicable diseases, and may also address diagnosis, or investigator driven clinical trials on treatments of particular relevance for patients with co-morbidities. The proposals should address combination(s) of any of the three major poverty-related diseases (HIV/AIDS, malaria or tuberculosis) or any of the neglected infectious diseases with non-infectious diseases of major importance, such as, but not limited to, rheumatic or cardiovascular diseases, cancer or diabetes.
HEALTH.2012.2.3.2-3: Prevention and treatment for HIV/AIDS, malaria and tuberculosis.
FP7-HEALTH-2012-INNOVATION-1. The supported projects should aim at developing innovative strategies for the prevention and/or treatment of poverty-related diseases HIV/AIDS, malaria or tuberculosis). Priority will be given to projects addressing current gaps in prevention and/or treatment and key research areas such as novel and combinatorial strategies for prevention, novel therapeutic and/or curative approaches,development of models for disease progression and host-pathogen interaction in humans.
Projects may contain elements of both basic and translational research. A detailed plan for development and exploitation of the end results will be an important aspect. The intention is to provide individual members of the consortium with sufficient resources to deliver results in the short term. Therefore, applications from small consortia (typically 3-5 partners) as well as short duration (typically 1-3 years) with up to the expected EU contribution are welcome.
Indicative official publication date for all documents including the final work programme is 20 July 2011.
FP7-HEALTH-2012-INNOVATION-1 indicative deadline 04 October 2011
Find out more on Cordis
First CHAARM newsletter published
Enjoy it!!
a “ path changer”
Surely the CAPRISA results can be seen as a "game changer" in the research on HIV microbicides. Also CHAARM consortium is discussing on the possibility to review something the research path already undertaken.
Global campaign for Microbicides
Study of Microbicide Gel on youTube
CHAARM at Microbicides2010
Sure, Chaarm project has been represented at the Microbicides2010 by a number of our project partners. For more details, please look at the newsroom section of the website, you will find listed all the presentations our partners have given!
The dissertation chapters
The dissertation chapters should be perfectly composed by distinguished thesis service, when people want to present a writing talent. Thus, this is manifestly that you understand the right way to finish a superb issue referring to this topic. Thank you very much for distributing this.
Generic Lanoxin Online
It is good to hear about the
It is good to hear about the CHAARM,where are you are in research to prevent from HIV and hope you will succed but as far as i came to know that the HIV can't be cured is it so?But i feel it should be cured and there should be a remarkable change in every one's life..
Online Pharmacy
Great article.
Great article. I have this read and find very informative.
Scot